Related Experiment Videos
The diversity of p53 mutations among human brain tumors and their functional consequences
Agata Zupanska1, Bozena Kaminska
1Laboratory of Transcription Regulation, Department of Cellular Biochemistry, Nencki Institute of Experimental Biology, 3 Pasteur Str., 02-093 Warsaw, Poland.
Abstract:
The p53 tumor suppressor is implicated in cell cycle control, DNA repair, replicative senescence and programmed cell death. Inactivation of the p53 contributes to the wide range of human tumors, including glial neoplasms. In this review, we describe the regulation and biochemical properties of p53 protein that may explain its ability to activate various genetic programs underlying cellular responses to stress conditions. The overall spectrum of p53 mutations is rather shared between tumor types indicating that these mutations are not tumor type-specific. However, there is one example of germ-line mutation of p53 gene (the deletion of the codon 236) that is associated with a familiar brain tumor syndrome. We compare the frequency and type of most common mutations among various brain tumours (focusing on glioblastomas) and their consequences on protein functions. Furthermore, we discuss the most promising approaches of potential brain tumor therapy, including an adenovirus-mediated p53 gene transfer. Human glioblastomas are highly sensitive to the effects of p53 activity when the wild-type p53 is introduced ectopically. It suggests that the genetic or pharmacological modulation of the p53 pathway is potentially important strategy in the treatment of human cancers.
Insights
The p53 tumor suppressor protein is crucial for preventing human tumors. Inactivating p53 mutations are common in brain tumors, and restoring wild-type p53 shows promise for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 tumor suppressor protein plays a vital role in cell cycle control, DNA repair, senescence, and apoptosis.
- Inactivation of p53 is a common event in various human cancers, including glial neoplasms.
- Understanding p53's regulation and biochemical properties is key to its role in cellular stress responses.
Purpose of the Study:
- To review the regulation and biochemical properties of p53 protein.
- To compare p53 mutation frequencies and types in brain tumors, particularly glioblastomas.
- To discuss novel therapeutic strategies involving p53 modulation for brain tumors.
Main Methods:
- Literature review focusing on p53 protein.
- Comparative analysis of p53 mutation data across different brain tumor types.
- Discussion of gene therapy approaches, including adenovirus-mediated p53 transfer.
Main Results:
- p53 mutations are generally not tumor-specific, but a germ-line mutation is linked to a familial brain tumor syndrome.
- Glioblastomas exhibit sensitivity to ectopic wild-type p53 introduction.
- The study highlights the consequences of p53 mutations on protein function.
Conclusions:
- Modulating the p53 pathway, either genetically or pharmacologically, presents a promising strategy for human cancer treatment.
- Adenovirus-mediated p53 gene transfer is a potential therapeutic approach for brain tumors.
- Restoring wild-type p53 function in glioblastomas demonstrates therapeutic potential.